Clinical Trials Review Articles
Clinical trials square measure experiments or observations drained clinical analysis. Such prospective medical specialty or activity analysis studies on human participants square measure designed to answer specific questions about medical specialty or activity interventions, together with new treatments (such as novel vaccines, drugs, dietary selections, dietary supplements, and medical devices) and illustrious interventions that warrant additional study and comparison. Clinical trials generate knowledge on safety and effectuality. They’re conducted solely when they need received
health authority/ethics committee approval within the country wherever approval of the medical care is sought-after. These authorities square measure answerable for vetting the risk/benefit quantitative relation of the trial—their approval doesn't mean the medical care is 'safe' or effective, solely that the trial could also be conducted.
Depending on product sort and development stage, investigators ab initio inscribe volunteers or patients into little pilot studies, and later on conduct more and more larger scale comparative studies. Clinical trials will vary in size and price, and that they will involve one centre or multiple centers, in one country or in multiple countries. Clinical study style aims to confirm the scientific validity and reliability of the results.
Costs for clinical trials will vary into the billions of bucks per
approved drug. The sponsor could also be a governmental organization or a pharmaceutical,
biotechnology or medical device company.
High Impact List of Articles
-
Improving cancer clinical trial design and clinical practice: the case for tobacco use in cancer patients
Graham W Warren, Erica N Peters
Editorial: Clinical Investigation
-
Improving cancer clinical trial design and clinical practice: the case for tobacco use in cancer patients
Graham W Warren, Erica N Peters
Editorial: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
Relevant Topics in Clinical